These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33468485)

  • 1. Limited Multidrug Resistance Efflux Pump Overexpression among Multidrug-Resistant Escherichia coli Strains of ST131.
    Camp J; Schuster S; Vavra M; Schweigger T; Rossen JWA; Reuter S; Kern WV
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131.
    Atac N; Kurt-Azap O; Dolapci I; Yesilkaya A; Ergonul O; Gonen M; Can F
    Curr Microbiol; 2018 Dec; 75(12):1661-1666. PubMed ID: 30283991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
    Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of
    Chowdhury N; Suhani S; Purkaystha A; Begum MK; Raihan T; Alam MJ; Islam K; Azad AK
    Microbiol Insights; 2019; 12():1178636119889629. PubMed ID: 31839709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate.
    Schuster S; Vavra M; Schweigger TM; Rossen JWA; Matsumura Y; Kern WV
    Int J Antimicrob Agents; 2017 Sep; 50(3):477-481. PubMed ID: 28689875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1-(1-naphthylmethyl)-piperazine on antimicrobial agent susceptibility in multidrug-resistant isogenic and veterinary Escherichia coli field strains.
    Marchetti ML; Errecalde J; Mestorino N
    J Med Microbiol; 2012 Jun; 61(Pt 6):786-792. PubMed ID: 22345599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2019 Garrod Lecture: MDR efflux in Gram-negative bacteria-how understanding resistance led to a new tool for drug discovery.
    Piddock LJV
    J Antimicrob Chemother; 2019 Nov; 74(11):3128-3134. PubMed ID: 31626705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors.
    Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
    Zhou X; Jia F; Liu X; Wang Y
    Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the Role of AcrAB-TolC Efflux Pumps in the Evolution of Antibiotic Resistance Reveals Near-MIC Treatments Facilitate Resistance Acquisition.
    Langevin AM; El Meouche I; Dunlop MJ
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33328350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and mechanism of triclosan resistance in Escherichia coli isolated from urine samples in Wenzhou, China.
    Zeng W; Xu W; Xu Y; Liao W; Zhao Y; Zheng X; Xu C; Zhou T; Cao J
    Antimicrob Resist Infect Control; 2020 Oct; 9(1):161. PubMed ID: 33008474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-
    Kanamori H; Parobek CM; Juliano JJ; Johnson JR; Johnston BD; Johnson TJ; Weber DJ; Rutala WA; Anderson DJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584139
    [No Abstract]   [Full Text] [Related]  

  • 13. Fitness trade-offs of multidrug efflux pumps in
    Liu Y; Van Horn AM; Pham MTN; Dinh BNN; Chen R; Raphael SDR; Paulino A; Thaker K; Somadder A; Frost DJ; Menke CC; Slimak ZC; Slonczewski JL
    Appl Environ Microbiol; 2024 Feb; 90(2):e0209623. PubMed ID: 38289137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Escherichia coli.
    Paltansing S; Tengeler AC; Kraakman ME; Claas EC; Bernards AT
    Microb Drug Resist; 2013 Dec; 19(6):469-76. PubMed ID: 23909485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli.
    Kern WV; Steinke P; Schumacher A; Schuster S; von Baum H; Bohnert JA
    J Antimicrob Chemother; 2006 Feb; 57(2):339-43. PubMed ID: 16354747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains.
    Cunrath O; Meinel DM; Maturana P; Fanous J; Buyck JM; Saint Auguste P; Seth-Smith HMB; Körner J; Dehio C; Trebosc V; Kemmer C; Neher R; Egli A; Bumann D
    EBioMedicine; 2019 Mar; 41():479-487. PubMed ID: 30852163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from
    Alenazy R
    Biology (Basel); 2022 Sep; 11(9):. PubMed ID: 36138807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps.
    Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Giovannelli L; Dei S; Teodori E
    J Antimicrob Chemother; 2022 Feb; 77(2):413-424. PubMed ID: 34747445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic
    Shaik S; Ranjan A; Tiwari SK; Hussain A; Nandanwar N; Kumar N; Jadhav S; Semmler T; Baddam R; Islam MA; Alam M; Wieler LH; Watanabe H; Ahmed N
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066550
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
    Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
    J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.